Clinical study on application of esketamine for postoperative analgesia after cesarean section in postpartum depression

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059451

Enrollment

Unknown

Registered

2022-04-29

Start date

2022-04-20

Completion date

Unknown

Last updated

2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum depression

Interventions

experimental group: Esketamine

control group:Hydromorphone

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the indications of cesarean section in Expert Consensus on Cesarean Section (2014); 2. Age 20-40 years old; 3. No previous history of immune system diseases and rheumatic diseases; 4. Clinical data and imaging data are complete.

Exclusion criteria

Exclusion criteria: 1. Combined with cardiovascular and cerebrovascular diseases; 2. Combined with vital organ insufficiency; 3. Coagulation dysfunction; 4. There is a history of lumbar surgery and severe trauma; 5. There is a history of allergy to non-steroidal anti-inflammatory drugs, opioid analgesics and other drugs; 6. Mental disorders, communication disorders.

Design outcomes

Primary

Measure	Time frame
Pain visual analogue scale;Edinburgh Depression Scale for Pregnancy;	—

Countries

China

Contacts

Public ContactTang Yanyan

Yongzhou Central Hospital of Hunan Province

duoduoj@163.com+86 15907479785

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026